Javascript must be enabled to continue!
The Role of TP53, KRAS, CDH1, Demographic and Clinical Variables in Gastric Cancer
View through CrossRef
Background: Worldwide, gastric cancer remains the fifth most prevalent type of cancer and is the third leading cause of cancer-related deaths. Gastric cancer is responsible for around 7% of global cancer occurrence and approximately 9% of annual cancer-related mortalities. Objective: The aim of the study was to analyze gastric cancer dataset posted on Kaggle (https://www.kaggle.com/datasets/datasetengineer/gastric-cancer-gc-dataset). Methods: This dataset comprises 212354 participants, of whom 10% had gastric cancer. This dataset was analyzed to extract the information regarding gastric cancer. The analysis of data was performed SPSS version 25. Descriptive analysis was used to describe data including frequency and percentages to describe categorical variables such as age, and the mean and standard deviation to describe non-categorical variables such as age. The relationships between variables and gastric cancer were calculated based on Chi-Square and One Way ANOVA tests, significance was considered if p value ≤0,05. Results: The mean age was 53.2580±18.98 years. Seventy percent of participants were males. About 30% of participants had a family history of gastric cancer. About 40% of participants were smokers. About 50% of participants were alcoholic. About 75% of participants had Helicobacter pylori. 80% of participants were at high salt intake. About 50% of participants had chronic gastritis. Abnormal endoscopic image reports were reported in approximately 30% of participants. Biopsy results were negative in 90% of participants. The reports of CT scans were negative in approximately 80%. Genetic mutations were detected in Tp53 (50.1%), KRAS (20%), and CDH1 (29,9%). No significant relationships were found between gastric cancer and study variables. Conclusion: Most of the people had risk factors such as Helicobacter pylori infection, salt intake, and mutations in TP53, KRAS, and CDH1. However, statistical analyses did not find significant correlations between those and gastric cancer.
Title: The Role of TP53, KRAS, CDH1, Demographic and Clinical Variables in Gastric Cancer
Description:
Background: Worldwide, gastric cancer remains the fifth most prevalent type of cancer and is the third leading cause of cancer-related deaths.
Gastric cancer is responsible for around 7% of global cancer occurrence and approximately 9% of annual cancer-related mortalities.
Objective: The aim of the study was to analyze gastric cancer dataset posted on Kaggle (https://www.
kaggle.
com/datasets/datasetengineer/gastric-cancer-gc-dataset).
Methods: This dataset comprises 212354 participants, of whom 10% had gastric cancer.
This dataset was analyzed to extract the information regarding gastric cancer.
The analysis of data was performed SPSS version 25.
Descriptive analysis was used to describe data including frequency and percentages to describe categorical variables such as age, and the mean and standard deviation to describe non-categorical variables such as age.
The relationships between variables and gastric cancer were calculated based on Chi-Square and One Way ANOVA tests, significance was considered if p value ≤0,05.
Results: The mean age was 53.
2580±18.
98 years.
Seventy percent of participants were males.
About 30% of participants had a family history of gastric cancer.
About 40% of participants were smokers.
About 50% of participants were alcoholic.
About 75% of participants had Helicobacter pylori.
80% of participants were at high salt intake.
About 50% of participants had chronic gastritis.
Abnormal endoscopic image reports were reported in approximately 30% of participants.
Biopsy results were negative in 90% of participants.
The reports of CT scans were negative in approximately 80%.
Genetic mutations were detected in Tp53 (50.
1%), KRAS (20%), and CDH1 (29,9%).
No significant relationships were found between gastric cancer and study variables.
Conclusion: Most of the people had risk factors such as Helicobacter pylori infection, salt intake, and mutations in TP53, KRAS, and CDH1.
However, statistical analyses did not find significant correlations between those and gastric cancer.
Related Results
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Abstract
Introduction
Higher-risk myelodysplastic syndromes (MDS) progress to secondary acute myeloid leukemia (sAML) within mon...
Kras Plays An Important Role In Generating Differentiated Blood Cells
Kras Plays An Important Role In Generating Differentiated Blood Cells
Abstract
Background
Kras is a small GTPase essential for mouse embryonic development. Although Kras-/- fetal liver cells reconst...
Comparison of TP53 Alterations in Hematological Malignancies
Comparison of TP53 Alterations in Hematological Malignancies
Abstract
Background: TP53 is altered in ~50% of human cancers. Alterations include mutations and deletions. Both frequently occur together, supportin...
Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy
Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy
Aims & Background Hereditary diffuse gastric cancer is a recently defined cancer syndrome caused by inactivating, heterozygous germline mutations in the E-cadherin gene (CDH1)....
Searching for CDH1 gene mutations in early-onset diffuse gastric cancer in Chinese patients.
Searching for CDH1 gene mutations in early-onset diffuse gastric cancer in Chinese patients.
23 Background: CDH1 germline mutations are found to be associated with the development of hereditary diffuse gastric cancer (HDGC) and the early-onset diffuse gastric cancer (EODG...
Abstract 4442: TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizing agents in monoclonal cells and comparison of clinical outcomes from The Cancer Genome Atlas data
Abstract 4442: TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizing agents in monoclonal cells and comparison of clinical outcomes from The Cancer Genome Atlas data
Abstract
TP53 is mutated in 96% of high grade serous epithelial ovarian carcinomas (HGS EOC) sequenced by The Cancer Genome Atlas (TCGA). Missense mutations at hot s...
Data from E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
Data from E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
<div>Abstract<p>The importance of loss of the cell-cell adhesion molecule E-cadherin (encoded by <i>CDH1</i>) to tumor progression is well established. Howe...
Data from E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
Data from E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man
<div>Abstract<p>The importance of loss of the cell-cell adhesion molecule E-cadherin (encoded by <i>CDH1</i>) to tumor progression is well established. Howe...

